Report Description

Stem cells are the foundation for every tissue and organ in the body. Stem cells are biological cells that can divide and can produce more stem cells. In human body, every organ and tissue grows clusters of stem cell. The global stem cell market is growing at a CAGR of 23.12% during the forecast period 2016-2023. The key trend of the global stem cell market is the increasing number of neurodegenerative diseases. Neurodegenerative diseases result in progressive degeneration or death of the nerve cells. According to Alzheimer’s organization about 5.4 million Americans of all ages had Alzheimer’s disease in 2016. With the increasing geriatric population diseases like Alzheimer’s and dementias are also increasing. Stem cells are widely used for the treatment of neurological diseases. The major drivers for the global stem cell market are as follows:

Funding and support of government
Rise in medical tourism is creating huge scope
Increasing stem cell banking
Increasing investments in R&D
Technological advancement enables to grow fast
Global rise in neurodegenerative diseases

Increasing investment in R&D is driving the global stem cell market. The overall R&D backing for stem cell research has increased in the past 5 to 10 years and is expected to reach desired statures in the years to come. The number of venture capital firms investing in stem cell study has increased and government funding agencies which have started to acknowledge the future benefits of the stem cell industry. The increasing prevalence of neurodegenerative disorders, development of the contract research industry, and replacement of animal tissue in drug detection are also anticipated to contribute towards the overall growth and also drives the stem cells market.

Stem cell therapy is succeeding to treat many progressive diseases and numerous clinical trials and case studies have proved that the stem cell therapy is a harmless treatment, providing treatment for diseases such as blood cancer, brain stroke/coma, spinal cord injury, retinitis pimentos, muscular dystrophy, autism, cerebral palsy, COPD and so more degenerative diseases. But these treatments are very high in costs, which is the major restraint for the global stem cell market.

Stringent government regulations act as a challenge for the global stem cell market. The lack of awareness about stem cell therapy in developing countries and in emerging economies is the major challenge for the global stem cell market.

Source: OBRC Analysis

The global stem cell market segmentation includes products, technology and application. Product is further sub segmented into:

Adult stem cell
Human embryonic stem cell
Induced pluripotent stem cell
Rat neutral stem cell
Others

Technology is further categorized into:

Stem cell acquisition
Stem cell production
Stem cell cryopreservation
Stem cells expansion and sub-culture

Application segment of global stem cell market is further categorized into:

Regenerative medicine
Drug discovery and development

The revenue for the above application segments are specific to the stem cell market. However, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product segment.

Geographically, the global stem cell market is segmented into:

North America (U.S. & Canada)
Asia Pacific (China, India, Japan, RoAPAC)
Europe (UK, France, Germany, RoE)
Rest of World

North America dominates the global stem cell market followed by Europe due to large prevalence of neurological and cardiac disorders, state creativities and delivery of grants from several organizations, development of innovative therapies, strong research activities, and active marketing solutions. The Asia Pacific stem cells market is anticipated to witness an impressive growth over the next 2 years due to rapidly growing contract research outsourcing and successful medical tourism.

Global stem cell market is segmented by product, by application and by technology. By product, the global stem cells market is sub segmented into adult stem cells, induced pluripotent stem cells, very small embryonic like stem cells, human embryonic stem cells, and rat neural stem cells. Adult stem cells, includes mesenchymal stem cells, dental stem cells, neuronal stem cells, hematopoietic stem cells, and umbilical cord stem cells. The adult stem cells segment holds the highest share in the global stem cells market due to the less tedious procedure of harvesting adult stem cells and greater acceptance of the same in the human body. On the basis of technology, global stem cell market is characterized into stem cell acquisition (it is the major as well as the fastest emerging technological segment and includes bone marrow harvesting, umbilical cord blood, and apheresis.), production (it includes cloning, isolation, in-vitro fertilization, and cell culture), cryopreservation, and expansion and sub-culture. On the basis of application, the stem cells market is characterized into regenerative medicine and drug detection and development. Regenerative medicine holds the higher share in the stem cells market and covers major disciplines such as orthopaedics, haematology, wound care, diabetes, incontinence, neurology, oncology, cardiovascular and myocardial infarction, spinal cord injuries, and liver disorders.

The major market players of the global stem cell market are:

ADVANCED CELL TECHNOLOGY
ASTROM BIOSCIENCES INC.
ANGEL BIOTECHNOLOGY
BIOHEART
BRAINSTORM CELL THERAPEUTICS
CALIFORNIA STEM CELL INC.
OTHERS

Detailed analysis of these companies provided in this report comprises of overview, scot analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as mergers & acquisitions, collaboration, partnership and product launching. For example: Thermos fisher scientific acquired stem cell firm MTI-GlobalStem in 2016. MTI-GlobalStem is a private firm specialized in the commercialization of reagents and tools for cell transfection and stem cell research application.

Why to buy the report:

This report:

Provide you the business strategies adopted by market player such as acquisitions, as in 2016, Thermos fisher scientific acquired stem cell firm MTI-GlobalStem.
Provide in detail the different segments such as products and end-users which affect the global stem cell market.
Provide you the patent analysis of global stem cell market.
Identify and understand the strengths, opportunities, challenges and threat of global stem cell market.
Provide revenues of major players of the global stem cell market.
Provide you the various regulatory policies which affect the global stem cell market.

How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global stem cell market offers the longest chain of market segmentation covering major market segmentation based on products, technology and application.The report tracks the major market trends in the global stem cell market such as growing number of ageing population and neurodegenerative diseases.For each market segments covered in global stem cell market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the stem cell market, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force models and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data.

Key findings of the global stem cell market:

North America had the largest revenue share in 2016.
Acquisition is the key strategy adopted by the various market players of global stem cell market.

Table of Content

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

2.1. GLOBAL STEM CELL MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES & ANALYSIS

2.8.2. MARKET SHARE ANALYSIS

2.8.3. TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. FUNDING AND SUPPORT OF GOVERNMENT

3.1.2. RISE IN MEDICAL TOURISM IS CREATING HUGE SCOPE

3.1.3. INCREASING STEM CELL BANKING

3.1.4. INCREASING INVESTMENTS IN R&D

3.1.5. TECHNOLOGICAL ADVANCEMENT ENABLES TO GROW FAST

3.1.6. GLOBAL RISE IN NEURODEGENERATIVE DISEASES ARE CREATING SCOPE

3.2. MARKET RESTRAINTS

3.2.1. BURSEMENT POLICIES MAY CREATE BURDEN IN THE GROWTH OF GLOBAL STEM CELL MARKET

3.2.2. HIGH COST OF TREATMENT

3.3. MARKET OPPORTUNITIES

3.3.1. HUGE SCOPE IN UNTAPPED APAC REGION

3.3.2. REPLACING ANIMAL TISSUE IN DRUG DISCOVERY

3.3.3. INCREASING DISPOSABLE INCOME ACROSS GEOGRAPHIES

3.3.4. CONTRACT RESEARCH INDUSTRY IS EXPECTED TO CONTRIBUTE

3.4. MARKET CHALLENGES

3.4.1. GOVERNMENT REGULATIONS MAY CREATE BURDEN

3.4.2. LESS AWARENESS IN EMERGING ECONOMIES

4. MARKET SEGMENTATION

4.1. GLOBAL STEM CELL MARKET BY PRODUCT

4.1.1. MARKET DEFINITION AND SCOPE

4.1.2. DECISION SUPPORT

4.1.3. DATABASE & ESTIMATION METHODOLOGY

4.1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.5. OPPORTUNITY MATRIX

4.1.6. MARKET SEGMENTATION

4.1.6.1. GLOBAL ADULT STEM CELL MARKET

4.1.6.1.1. APPLICATION

4.1.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.1.4. TOP PLAYERS & KEY PRODUCTS

4.1.6.1.5. KEY CONCLUSIONS

4.1.6.2. GLOBALHUMAN EMBRYONIC STEM CELL MARKET

4.1.6.2.1. APPLICATION

4.1.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.2.4. TOP PLAYERS & KEY PRODUCTS

4.1.6.2.5. KEY CONCLUSIONS

4.1.6.3. GLOBAL INDUCED PLURIPOTENT MARKET

4.1.6.3.1. APPLICATION

4.1.6.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.3.4. TOP PLAYERS & KEY PRODUCTS

4.1.6.3.5. KEY CONCLUSIONS

4.1.6.4. GLOBAL RAT NEURAL MARKET

4.1.6.4.1. APPLICATION

4.1.6.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.4.4. TOP PLAYERS & KEY PRODUCTS

4.1.6.4.5. KEY CONCLUSIONS

4.1.6.5. GLOBAL OTHER MARKET

4.1.6.5.1. APPLICATION

4.1.6.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.5.4. TOP PLAYERS & KEY PRODUCTS

4.1.6.5.5. KEY CONCLUSIONS

4.2. GLOBAL STEM CELL MARKET BY TECHNOLOGY

4.2.1. MARKET DEFINITION AND SCOPE

4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4. OPPORTUNITY MATRIX

4.2.5. MARKET SEGMENTATION

4.2.5.1. GLOBAL ACQUISITION MARKET

4.2.5.1.1. APPLICATION

4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5. KEY CONCLUSIONS

4.2.5.2. GLOBAL CRYOPRESERVATION MARKET

4.2.5.2.1. APPLICATION

4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5. KEY CONCLUSIONS

4.2.5.3. GLOBAL EXPANSION AND SUB-CULTURE MARKET

4.2.5.3.1. APPLICATION

4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5. KEY CONCLUSIONS

4.3. GLOBAL STEM CELL MARKET BY APPLICATION

4.3.1. MARKET DEFINITION AND SCOPE

4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4. OPPORTUNITY MATRIX

4.3.5. MARKET SEGMENTATION

4.3.5.1. GLOBAL REGENERATIVE MEDICINE MARKET

4.3.5.1.1. APPLICATION

4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.1.5. KEY CONCLUSIONS

4.3.5.2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET

4.3.5.2.1. APPLICATION

4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.2.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1. LIST OF MERGERS & ACQUISITION

5.1.2. LIST OF JOINT VENTURES

5.1.3. LIST OF PRODUCT LAUNCHES

5.1.4. LIST OF PARTNERSHIPS

5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4. GLOBAL STEM CELL MARKET BY REGION

6.4.1. NORTH AMERICA

6.4.1.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.1.2. TOP COUNTRY ANALYSIS

6.4.1.2.1. U.S.

6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3. KEY CONCLUSIONS

6.4.1.2.2. CANADA

6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3. KEY CONCLUSIONS

6.4.2. EUROPE

6.4.2.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.2.2. TOP COUNTRY ANALYSIS

6.4.2.2.1. UK

6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3. KEY CONCLUSIONS

6.4.2.2.2. FRANCE

6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3. KEY CONCLUSIONS

6.4.2.2.3. GERMANY

6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3. KEY CONCLUSIONS

6.4.2.2.4. SPAIN

6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3. KEY CONCLUSIONS

6.4.2.2.5. REST OF EUROPE

6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3. KEY CONCLUSIONS

6.4.3. ASIA PACIFIC

6.4.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.3.2. TOP COUNTRY ANALYSIS

6.4.3.2.1. CHINA

6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3. KEY CONCLUSIONS

6.4.3.2.2. INDIA

6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3. KEY CONCLUSIONS

6.4.3.2.3. JAPAN

6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3. KEY CONCLUSIONS

6.4.3.2.4. AUSTRALIA

6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3. KEY CONCLUSIONS

6.4.3.2.5. REST OF ASIA PACIFIC

6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3. KEY CONCLUSIONS

6.4.4. ROW

6.4.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.4.2. TOP COUNTRY ANALYSIS

6.4.4.2.1. LATIN AMERICA

6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3. KEY CONCLUSIONS

6.4.4.2.2. MIDDLE EAST & AFRICA

6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

7.1. ADVANCED CELL TECHNOLOGY

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY INNOVATION SECTOR

7.1.4. STRATEGIC INITIATIVES

7.1.5. SCOT ANALYSIS

7.1.6. STRATEGIC ANALYSIS

7.2. AASTROM BIOSCIENCES INC..

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY INNOVATION SECTOR

7.2.4. STRATEGIC INITIATIVES

7.2.5. SCOT ANALYSIS

7.2.6. STRATEGIC ANALYSIS

7.3. ANGEL BIOTECHNOLOGY

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY INNOVATION SECTOR

7.3.4. STRATEGIC INITIATIVES

7.3.5. SCOT ANALYSIS

7.3.6. STRATEGIC ANALYSIS

7.4. BIOHEART

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY INNOVATION SECTOR

7.4.4. STRATEGIC INITIATIVES

7.4.5. SCOT ANALYSIS

7.4.6. STRATEGIC ANALYSIS

7.5. BRAINSTORM CELL THERAPEUTICS

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY INNOVATION SECTOR

7.5.4. STRATEGIC INITIATIVES

7.5.5. SCOT ANALYSIS

7.5.6. STRATEGIC ANALYSIS

7.6. CALIFORNIA STEM CELL INC.

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY INNOVATION SECTOR

7.6.4. STRATEGIC INITIATIVES

7.6.5. SCOT ANALYSIS

7.6.6. STRATEGIC ANALYSIS

7.7. CELGENE CORPORATION

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY INNOVATION SECTOR

7.7.4. STRATEGIC INITIATIVES

7.7.5. SCOT ANALYSIS

7.7.6. STRATEGIC ANALYSIS

7.8. CELLULAR DYNAMICS INTERNATIONAL

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY INNOVATION SECTOR

7.8.4. STRATEGIC INITIATIVES

7.8.5. SCOT ANALYSIS

7.8.6. STRATEGIC ANALYSIS

7.9. CYTORI THERAPEUTICS INC.

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY INNOVATION SECTOR

7.9.4. STRATEGIC INITIATIVES

7.9.5. SCOT ANALYSIS

7.9.6. STRATEGIC ANALYSIS

7.10. FIBROCELL SCIENCE

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY INNOVATION SECTOR

7.10.4. STRATEGIC INITIATIVES

7.10.5. SCOT ANALYSIS

7.10.6. STRATEGIC ANALYSIS

7.11. CELLARTIS AB

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY INNOVATION SECTOR

7.11.4. STRATEGIC INITIATIVES

7.11.5. SCOT ANALYSIS

7.11.6. STRATEGIC ANALYSIS

7.12. CYTORI THERAPEUTICS INC.

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY INNOVATION SECTOR

7.12.4. STRATEGIC INITIATIVES

7.12.5. SCOT ANALYSIS

7.12.6. STRATEGIC ANALYSIS

7.13. BIOTIME INC.

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY INNOVATION SECTOR

7.13.4. STRATEGIC INITIATIVES

7.13.5. SCOT ANALYSIS

7.13.6. STRATEGIC ANALYSIS

7.14. OSIRIS THERAPEUTICS

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY INNOVATION SECTOR

7.14.4. STRATEGIC INITIATIVES

7.14.5. SCOT ANALYSIS

7.14.6. STRATEGIC ANALYSIS

7.15. GE HEALTHCARE

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY INNOVATION SECTOR

7.15.4. STRATEGIC INITIATIVES

7.15.5. SCOT ANALYSIS

7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

1. GLOBAL STEM CELL MARKET BY PRODUCT 2014-2023 ($ MILLION)

2. GLOBAL ADULT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

3. GLOBAL HUMAN EMBRYONIC MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

4. GLOBAL INDUCED PLURIPOTENT BY GEOGRAPHY 2014-2023 ($ MILLION)

5. GLOBAL RAT NEUTRAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

6. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

7. GLOBAL STEM CELL MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)

8. GLOBAL ACQUISITION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

9. GLOBAL PRODUCTION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

10. GLOBAL CRYOPRESERVATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

11. GLOBAL EXPANSION AND SUB-CULTURE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

12. GLOBAL STEM CELL MARKET BY APPLICATION 2014-2023 ($ MILLION)

13. GLOBAL REGENERATIVE MEDICINE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION

14. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION

15. NORTH AMERICA STEM CELL MARKET 2014-2023 ($ MILLION)

16. EUROPE STEM CELL MARKET 2014-2023 ($ MILLION)

17. ASIA PACIFIC STEM CELL MARKET 2014-2023 ($ MILLION)

18. REST OF THE WORLD STEM CELL MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

1. GLOBAL STEM CELL MARKET BY ADULT STEM CELL 2014-2023 ($ MILLION)

2. GLOBAL STEM CELL MARKET BY HUMAN EMBRYONIC STEM CELL 2014-2023 ($ MILLION)

3. GLOBAL STEM CELL MARKET BY INDUCED PLURIPOTENT STEM CELL 2014-2023 ($ MILLION)

4. GLOBAL STEM CELL MARKET BY RAT NEUTRAL STEM CELL 2014-2023 ($ MILLION)

5. GLOBAL STEM CELL MARKET BY OTHERS 2014-2023 ($ MILLION)

6. GLOBAL STEM CELL MARKET BY STEM CELL ACQUISITION 2014-2023 ($ MILLION)

7. GLOBAL STEM CELL BY STEM CELL PRODUCTION 2014-2023 ($ MILLION)

8. GLOBAL STEM CELL MARKETBY STEM CELL CRYOPRESERVATION 2014-2023 ($ MILLION)

9. GLOBAL STEM CELL MARKET BY STEM CELLS EXPANSION AND SUB-CULTURE 2014-2023 ($ MILLION)

10. GLOBAL STEM CELL MARKET BY REGENERATIVE MEDICINE 2014-2023 ($ MILLION

11. GLOBAL STEM CELL MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2014-2023 ($ MILLION

12. UNITED STATES (U.S.) STEM CELL MARKET 2014-2023 ($ MILLION)

13. CANADA STEM CELL MARKET 2014-2023 ($ MILLION)

14. UNITED KINGDOM (UK) STEM CELL MARKET 2014-2023 ($ MILLION)

15. FRANCE STEM CELL MARKET 2014-2023 ($ MILLION)

16. GERMANY STEM CELL MARKET 2014-2023 ($ MILLION)

17. SPAIN STEM CELL MARKET 2014-2023 ($ MILLION)

18. ROE STEM CELL MARKET 2014-2023 ($ MILLION)

19. INDIA STEM CELL MARKET 2014-2023 ($ MILLION)

20. CHINA STEM CELL MARKET 2014-2023 ($ MILLION)

21. JAPAN STEM CELL MARKET 2014-2023 ($ MILLION)

22. AUSTRALIA STEM CELL MARKET 2014-2023 ($ MILLION)

23. ROAPAC STEM CELL MARKET 2014-2023 ($ MILLION)

24. LATIN AMERICA STEM CELL MARKET 2014-2023 ($ MILLION)

25. MENA STEM CELL MARKET 2014-2023 ($ MILLION)

Enquiry before Buying

FAQ

How can I purchase a report?

We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.

How safe is to use my credit card? Is my information secure?

We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.

Can I get a discount?

We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.

I want to buy only a chapter. I don't need complete report.

Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.

Can I get reports on my desired topic specially which is not available in your current portfolio?

Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.

When do I get access to the report(s) that I have purchased?

We will email you your purchased report right after we receive your payment through any of the payment options.

Will I receive any invoice for my purchase?

Yes we will email you invoice/payment confirmation with the order details once we receive your payment.

In what format will the reports be available in?

All the reports will be available in PDF format for download.

Request for Sample

Name*

Email Id*

Phone

Designation

Company Name

Country

Report Title

Type Characters*

Login

Forgot Password

Thank you for your request!

Thank you for downloading..!

Global Stem Cell Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

FAQ

Request for Sample

UPCOMING REPORTS

NAVIGATION LINK

OUR SERVICES

CONNECT WITH US